Sean Maduck
Net Worth
Last updated:
What is Sean Maduck net worth?
The estimated net worth of Mr. Sean Maduck is at least $21,070,558 as of 13 May 2024. He owns shares worth $6,050,762 as insider, has earned $10,200,016 from insider trading and has received compensation worth at least $4,819,780 in Corcept Therapeutics Incorporated.
What is the salary of Sean Maduck?
Mr. Sean Maduck salary is $688,540 per year as Chief Commercial Officer in Corcept Therapeutics Incorporated.
How old is Sean Maduck?
Mr. Sean Maduck is 48 years old, born in 1977.
What stocks does Sean Maduck currently own?
As insider, Mr. Sean Maduck owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Corcept Therapeutics Incorporated (CORT) | Chief Commercial Officer | 85,222 | $71 | $6,050,762 |
What does Corcept Therapeutics Incorporated do?
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with advanced ovarian tumors, as well as for the treatment of cortisol excess. The company is also developing selective cortisol modulator to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain and other disorders; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was incorporated in 1998 and is headquartered in Menlo Park, California.
Sean Maduck insider trading
Corcept Therapeutics Incorporated
Mr. Sean Maduck has made 25 insider trades between 2018-2024, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 60,000 units of CORT stock on 12 Dec 2018. As of 13 May 2024 he still owns at least 85,222 units of CORT stock.